On July 31, 2007 the Company shocked investors when it reported abysmal second quarter 2007 financial and operational results, which included a decline in same-store procedure volume and a substantial rise in patient acquisition costs. Additionally, the Company reported lowering operating income, net income, and earnings per share ("EPS") than in the comparable 2006 quarter. As a result, the Company significantly lowered its EPS guidance from between $2.05 to $2.15 for full-year 2007 down to between $1.90 to $2.00 for full-year 2007.
On this news, the Company's shares declined $7.48 per share, or 17.4 percent, to close on July 31, 2007 at $35.51 per share, on unusually heavy trading volume. The following day, the Company's shares declined an additional $2.11 per share, or almost 6 percent, to close on August 1, 2007 at $33.40 per share, again on heavy trading volume.
Plaintiff seeks to recover damages on behalf of class members and is represented by the law firm of Schiffrin Barroway Topaz & Kessler which prosecutes class actions in both state and federal courts throughout the country. Schiffrin Barroway Topaz & Kessler is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world.
For more information about Schiffrin Barroway Topaz & Kessler or to sign up to participate in this action online, please visit http://www.sbtklaw.com
If you are a member of the class described above, you may, not later
than November 13, 2007, move the Court to serve as lead plaintiff of the
class, if you so choose. A lead plaintiff is a representative party that
acts on behalf of other class members in directing the litigation. In order
to be appointed lead plaintiff, the Court must determine that the class
member's claim is typical of the claims of other
|SOURCE Schiffrin Barroway Topaz & Kessler, LLP|
Copyright©2007 PR Newswire.
All rights reserved